1. Home
  2. FRSX vs BRTX Comparison

FRSX vs BRTX Comparison

Compare FRSX & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foresight Autonomous Holdings Ltd.

FRSX

Foresight Autonomous Holdings Ltd.

HOLD

Current Price

$1.26

Market Cap

5.1M

Sector

Technology

ML Signal

HOLD

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$2.75

Market Cap

3.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRSX
BRTX
Founded
N/A
1997
Country
Israel
United States
Employees
74
14
Industry
Computer Software: Prepackaged Software
Managed Health Care
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
3.7M
IPO Year
2016
2015

Fundamental Metrics

Financial Performance
Metric
FRSX
BRTX
Price
$1.26
$2.75
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
81.7K
212.3K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$81,000.00
Revenue This Year
N/A
$298.39
Revenue Next Year
N/A
$64.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.78
$0.14
52 Week High
$3.00
$4.10

Technical Indicators

Market Signals
Indicator
FRSX
BRTX
Relative Strength Index (RSI) 55.28 62.93
Support Level $1.21 $0.45
Resistance Level $1.47 $4.10
Average True Range (ATR) 0.08 0.41
MACD 0.01 0.12
Stochastic Oscillator 67.86 65.37

Price Performance

Historical Comparison
FRSX
BRTX

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the development of 3D perception systems and cellular-based applications. The company designs, develops, and commercializes in-line-of-sight vision systems and beyond-line-of-sight accident prevention solutions through its subsidiaries. Its solutions are based on stereo vision, 3D perception, and V2X technologies, aimed at improving safety by enabling accurate obstacle detection and real-time alerts. The company targets multiple industries, including automotive, defense, agriculture, and heavy equipment.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.

Share on Social Networks: